This is a prospective randomized phase II clinical trial where patients who are receiving enzalutamide in the pre-chemotherapy space are...
The European Commission has granted EU marketing authorisation in 28 countries for Vargatef (nintedanib), from Boehringer, in combination with docetaxel...
Following a review by NICE in the UK, Vargatef (nintedanib), from Boehringer, in combination with docetaxel has been recommended for...
Randomised controlled trial (RCT) data suggest that docetaxel (formerly Taxotere from Sanofi and now generic) improves overall survival and time...